Pharmatec Engineering ApS: Financial statements 2022
CVR: 37819859
Source: annual report 2022, Danish Business Authority
01/01/2022 – 31/12/2022
Pharmatec Engineering ApS (CVR 37819859) has filed annual accounts for 2022. In 2022, the company reported a gross profit of DKK 1,335,545 and a net result of DKK 258,321 compared with DKK 305,502 the year before. That is an increase of 33.9% compared with the year before. Equity in the 2022 report amounted to DKK 1,242,477. The solvency ratio was 84%. The company had 1 employee in the financial year.
- Gross Profit
- DKK 1,335,545
- Profit/Loss
- DKK 258,321
- Equity
- DKK 1,242,477
- Total Assets
- DKK 1,479,202
- Employees
- 1
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2022 | - | 1.3 mio. | 258 t. | 1.2 mio. | 1 |
| 2021 | - | 997 t. | 306 t. | 1.1 mio. | 1 |
| 2020 | - | 840 t. | 309 t. | 793 t. | 1 |
| 2019 | - | 528 t. | 58 t. | 556 t. | 1 |
| 2018 | - | 588 t. | -18 t. | 579 t. | - |
Keep an eye on Pharmatec Engineering ApS
Get notified instantly about new financial statements, ownership changes, management changes and status changes.
Set up monitoringEvents in 2022
Pharmatec Engineering ApS has published its annual report for 2021. Gross profit came to DKK 997,399, and the net result was DKK 305,502.
About Pharmatec Engineering ApS
Pharmatec Engineering ApS is a Danish company of the type Anpartsselskab based in Roskilde, founded in 2016. The company is registered under the industry Andre liberale, videnskabelige og tekniske tjenesteydelser i.a.n.. The management consists of Kim Fasting. The company is owned by Kim Fasting. The company has 1 employee (2018). In 2025, the company reported a gross profit of DKK 1,380,062 and a net result of DKK 2,278,538 compared with DKK 323,508 the year before. Equity in the 2025 report amounted to DKK 4,028,336.